MedWatch

Novo Seeds starts new consulting company: "The need is huge"

Novo Seeds has started the company Biorigin, which with a number of experienced life science people attached, will serve as an advisory unit for the Seed fund. "The need is huge and also bigger than the small initiative we have started with here," says Senior Partner Stephan Christgau.

Foto: Privat, PR

Last Thursday, Novo Seeds, which is in charge of the early investment initiatives for the private equity fund Novo Holdings, formally launched a new advisory department for life science companies in the early stages. It will be placed in the company Biorigin, which is owned and financed by Novo Seeds, however, it will be operated independently from the fund.

The decision to create the new advisory company is due to the increased need for help and guidance in the many early projects that receive funding from either Novo Seeds or the so-called pre-seed grants from the Novo Nordisk Foundation.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier